The latest news, announcements and press releases from SVF Vaccines.
SVF Vaccines AB (“SVF Vaccines” or the “Company”), a Swedish biotechnology company developing vaccines and immunotherapies for serious infectious diseases, today announced a collaboration with Touchlight, a biotechnology company specialising in cell-free DNA manufacturing, to accelerate the continued advancement of the Company’s lead hepatitis B/D immunotherapy program, SVF-001, toward clinical development.
This is the News section of the company profile page for SVF Vaccines on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.